Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality

被引：25
作者：
Hebart, H [1 ]
Brugger, W
Grigoleit, U
Gscheidle, B
Loeffler, J
Schafer, H
Kanz, L
Einsele, H
Sinzger, C
机构：
[1] Univ Tubingen, Med Klin & Poliklin, Abt 2, D-7400 Tubingen, Germany
[2] Univ Tubingen, Inst Hyg, Abt Med Virol, Tubingen, Germany
来源：
BLOOD | 2001年 / 97卷 / 07期
关键词：
D O I：
10.1182/blood.V97.7.2183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2183 / 2185
页数：3
相关论文
共 9 条
  • [1] BOECKH M, 1996, BLOOD S1, V88, pA643
  • [2] EINSELE H, 1995, BLOOD, V86, P2815
  • [3] Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
    Einsele, H
    Hebart, H
    Kauffman-Schneider, C
    Sinzger, C
    Jahn, G
    Bader, P
    Klingebiel, T
    Dietz, K
    Löffler, J
    Bokemeyer, C
    Müller, CA
    Kanz, L
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 757 - 763
  • [4] Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation
    Hebart, H
    Schroder, A
    Loffler, J
    Klingebiel, T
    Martin, H
    Wassmann, B
    Gerneth, F
    Rabenau, H
    Jahn, G
    Kanz, L
    Muller, CA
    Einsele, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) : 1490 - 1493
  • [5] Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
    Holmberg, LA
    Boeckh, M
    Hooper, H
    Leisenring, W
    Rowley, S
    Heimfeld, S
    Press, O
    Maloney, DG
    McSweeney, P
    Corey, L
    Maziarz, RT
    Appelbaum, FR
    Bensinger, W
    [J]. BLOOD, 1999, 94 (12) : 4029 - 4035
  • [6] Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease
    Krause, H
    Hebart, H
    Jahn, G
    Muller, CA
    Einsele, H
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (11) : 1111 - 1116
  • [7] RECOVERY OF HLA-RESTRICTED CYTOMEGALOVIRUS (CMV)-SPECIFIC T-CELL RESPONSES AFTER ALLOGENEIC BONE-MARROW TRANSPLANT - CORRELATION WITH CMV DISEASE AND EFFECT OF GANCICLOVIR PROPHYLAXIS
    LI, CR
    GREENBERG, PD
    GILBERT, MJ
    GOODRICH, JM
    RIDDELL, SR
    [J]. BLOOD, 1994, 83 (07) : 1971 - 1979
  • [8] Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients
    Nguyen, Q
    Champlin, R
    Giralt, S
    Rolston, H
    Raad, I
    Jacobson, K
    Ippoliti, C
    Hecht, D
    Tarrand, J
    Luna, M
    Whimbey, E
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) : 618 - 623
  • [9] Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions
    Small, TN
    Papadopoulos, EB
    Boulad, F
    Black, P
    Castro-Malaspina, H
    Childs, BH
    Collins, N
    Gillio, A
    George, D
    Jakubowski, A
    Heller, G
    Fazzari, M
    Kernan, N
    MacKinnon, S
    Szabolcs, P
    Young, JW
    O'Reilly, RJ
    [J]. BLOOD, 1999, 93 (02) : 467 - 480
1